Yann Godet

1.5k total citations
46 papers, 1.1k citations indexed

About

Yann Godet is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yann Godet has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 26 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Yann Godet's work include Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (17 papers). Yann Godet is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (17 papers). Yann Godet collaborates with scholars based in France, United States and Switzerland. Yann Godet's co-authors include Olivier Adotévi, Jeanne Galaine, Christophe Borg, Christophe Borg, Francine Jotereau, Brigitte Dréno, Virginie Vignard, Amir Khammari, Magalie Dosset and Romain Loyon and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yann Godet

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yann Godet France 19 623 591 359 106 86 46 1.1k
Teresa Lozano Spain 20 717 1.2× 481 0.8× 393 1.1× 133 1.3× 75 0.9× 43 1.2k
Michael J. Allegrezza United States 15 707 1.1× 737 1.2× 641 1.8× 124 1.2× 109 1.3× 18 1.4k
Cinzia Remondo Italy 12 479 0.8× 517 0.9× 216 0.6× 65 0.6× 96 1.1× 16 795
Annechien Plat Netherlands 15 538 0.9× 544 0.9× 286 0.8× 88 0.8× 67 0.8× 33 1.0k
Diana Llópiz Spain 19 700 1.1× 518 0.9× 351 1.0× 90 0.8× 65 0.8× 34 1.2k
Danielle M. Lussier United States 6 518 0.8× 534 0.9× 274 0.8× 162 1.5× 199 2.3× 8 990
Jason M. Redman United States 16 583 0.9× 571 1.0× 284 0.8× 48 0.5× 112 1.3× 53 1.0k
Lupe G. Salazar United States 17 878 1.4× 787 1.3× 362 1.0× 47 0.4× 88 1.0× 42 1.2k
Alexander Pedroza‐González Mexico 15 1.0k 1.6× 854 1.4× 274 0.8× 118 1.1× 134 1.6× 26 1.6k

Countries citing papers authored by Yann Godet

Since Specialization
Citations

This map shows the geographic impact of Yann Godet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yann Godet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yann Godet more than expected).

Fields of papers citing papers by Yann Godet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yann Godet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yann Godet. The network helps show where Yann Godet may publish in the future.

Co-authorship network of co-authors of Yann Godet

This figure shows the co-authorship network connecting the top 25 collaborators of Yann Godet. A scholar is included among the top collaborators of Yann Godet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yann Godet. Yann Godet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dehecq, Barbara, et al.. (2025). Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies. Cancer Immunology Immunotherapy. 74(7). 200–200. 1 indexed citations
2.
Royer, Bernard, Paul Peixoto, Barbara Dehecq, et al.. (2025). Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history. Molecular Therapy — Methods & Clinical Development. 33(3). 101553–101553. 1 indexed citations
3.
Abhishek, Kumar, Francis Bonnefoy, Maxime Fredon, et al.. (2024). Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy. Frontiers in Immunology. 15. 1202017–1202017.
4.
Godet, Yann, et al.. (2022). Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers. 14(1). 260–260. 41 indexed citations
5.
Nardin, Charlée, Caroline Laheurte, E. Puzenat, et al.. (2021). Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma. Journal of Investigative Dermatology. 142(2). 435–444. 13 indexed citations
6.
Bellanger, Anne‐Pauline, et al.. (2020). Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro. Parasite Immunology. 42(6). 9 indexed citations
7.
Kroemer, Marie, Célia Turco, Laurie Spehner, et al.. (2020). Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases. Journal for ImmunoTherapy of Cancer. 8(2). e001478–e001478. 31 indexed citations
8.
Galaine, Jeanne, Célia Turco, Charline Vauchy, et al.. (2019). CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin. International Journal of Cancer. 145(11). 3112–3125. 36 indexed citations
9.
Deschamps, Marina, Christophe Ferrand, Charline Vauchy, et al.. (2018). Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Human Gene Therapy. 29(10). 1202–1212. 9 indexed citations
10.
Jary, Marine, Thierry Lecomte, Olivier Bouché, et al.. (2016). Prognostic value of baseline seric Syndecan‐1 in initially unresectable metastatic colorectal cancer patients: a simple biological score. International Journal of Cancer. 139(10). 2325–2335. 15 indexed citations
11.
Laheurte, Caroline, Jeanne Galaine, Magalie Dosset, et al.. (2016). Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+Th1 responses against telomerase in cancer patients. OncoImmunology. 5(5). e1137416–e1137416. 18 indexed citations
12.
Jary, Marine, Déwi Vernerey, Thierry Lecomte, et al.. (2015). Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 24(3). 603–612. 16 indexed citations
13.
Aubin, F., Éric Toussirot, Francine Garnache‐Ottou, et al.. (2015). New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies. Experimental Hematology and Oncology. 5(1). 10–10. 17 indexed citations
14.
Dosset, Magalie, et al.. (2013). Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination. OncoImmunology. 2(3). e23430–e23430. 11 indexed citations
15.
Dosset, Magalie, Yann Godet, Charline Vauchy, et al.. (2012). Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor. Clinical Cancer Research. 18(22). 6284–6295. 47 indexed citations
16.
Godet, Yann, Elizabeth Fabre, Magalie Dosset, et al.. (2012). Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response. Clinical Cancer Research. 18(10). 2943–2953. 76 indexed citations
17.
Dobi, Erion, Franck Monnien, Stéfano Kim, et al.. (2012). Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 12(1). 28–36. 34 indexed citations
18.
Moreau‐Aubry, Agnès, Virginie Vignard, Yann Godet, et al.. (2010). Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas. PLoS ONE. 5(1). e8437–e8437. 74 indexed citations
19.
Larrieu, Pierre, et al.. (2007). A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes. Cancer Immunology Immunotherapy. 57(5). 745–752. 6 indexed citations
20.
Benlalam, Houssem, Virginie Vignard, Amir Khammari, et al.. (2006). Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunology Immunotherapy. 56(4). 515–526. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Lozano Breakdown of academic impact, for papers by Michael J. Allegrezza Breakdown of academic impact, for papers by Cinzia Remondo Breakdown of academic impact, for papers by Annechien Plat Breakdown of academic impact, for papers by Diana Llópiz Breakdown of academic impact, for papers by Danielle M. Lussier Breakdown of academic impact, for papers by Jason M. Redman Breakdown of academic impact, for papers by Lupe G. Salazar Breakdown of academic impact, for papers by Alexander Pedroza‐González
Rankless by CCL
2026